Replies to post #30529 on Ocata Therapeutics Inc fka OCAT

[rocky301]

louisa,


ACT has noted that they can fund operations into 2012. From CC yesterday they are projecting $5-7MM for Phase 1 SMD-AMD at least the way I understood it. I was figuring twice that amount but that was based on more patients, not 6. So ACT is comfortable where they are at for now and that isn't based on any other grant/funding that might come their way.

Also a note from prior post. Approx. 50 Million less warrants than what we saw in year end 10K numbers. If those were the CD holders .10 warrants then that translates into $5MM into ACT coffers too. So, with no intent or reason to do funding at the current pps levels, the $21MM is still available for the future. EXAMPLE ONLY: If PPS were to be .50 at year end, it would only take 42MM shares for the $21MM. Does that help?..thanks